Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$22.0 - $69.71 $3.57 Million - $11.3 Million
-162,239 Reduced 58.85%
113,431 $7.6 Million
Q1 2024

May 09, 2024

SELL
$25.72 - $29.94 $450,794 - $524,758
-17,527 Reduced 5.98%
275,670 $7.48 Million
Q4 2023

Feb 13, 2024

SELL
$23.42 - $31.74 $107,732 - $146,004
-4,600 Reduced 1.54%
293,197 $9.09 Million
Q3 2023

Nov 09, 2023

SELL
$19.86 - $26.93 $171,789 - $232,944
-8,650 Reduced 2.82%
297,797 $7.52 Million
Q2 2023

Aug 14, 2023

SELL
$16.44 - $21.1 $149,571 - $191,967
-9,098 Reduced 2.88%
306,447 $6.47 Million
Q1 2023

May 11, 2023

SELL
$16.26 - $21.73 $58,389 - $78,032
-3,591 Reduced 1.13%
315,545 $5.38 Million
Q4 2022

Jan 23, 2023

SELL
$16.98 - $23.15 $90,061 - $122,787
-5,304 Reduced 1.63%
319,136 $0
Q3 2022

Oct 18, 2022

SELL
$20.88 - $28.21 $191,887 - $259,249
-9,190 Reduced 2.75%
324,440 $6.99 Million
Q2 2022

Jul 15, 2022

BUY
$17.07 - $25.71 $162,182 - $244,270
9,501 Added 2.93%
333,630 $6.58 Million
Q1 2022

Apr 14, 2022

SELL
$20.42 - $28.13 $8,801 - $12,124
-431 Reduced 0.13%
324,129 $7.62 Million
Q4 2021

Jan 14, 2022

SELL
$25.89 - $33.45 $189,126 - $244,352
-7,305 Reduced 2.2%
324,560 $8.84 Million
Q3 2021

Oct 13, 2021

SELL
$22.46 - $29.47 $102,417 - $134,383
-4,560 Reduced 1.36%
331,865 $9.14 Million
Q2 2021

Jul 23, 2021

BUY
$24.17 - $36.01 $280,492 - $417,896
11,605 Added 3.57%
336,425 $9.58 Million
Q1 2021

Apr 09, 2021

BUY
$32.28 - $44.3 $1.05 Million - $1.44 Million
32,565 Added 11.14%
324,820 $11.1 Million
Q4 2020

Jan 12, 2021

BUY
$31.45 - $40.54 $251,600 - $324,320
8,000 Added 2.81%
292,255 $9.73 Million
Q3 2020

Oct 13, 2020

BUY
$26.0 - $34.5 $1.28 Million - $1.7 Million
49,161 Added 20.91%
284,255 $9.14 Million
Q2 2020

Jul 14, 2020

BUY
$14.11 - $29.42 $1.47 Million - $3.06 Million
104,169 Added 79.56%
235,094 $6.47 Million
Q1 2020

Apr 16, 2020

BUY
$13.63 - $33.98 $1.78 Million - $4.45 Million
130,925 New
130,925 $2.1 Million

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $9.48B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Scout Investments, Inc. Portfolio

Follow Scout Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Scout Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Scout Investments, Inc. with notifications on news.